Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

GHRP-6 Acetate Muscle Growth Complete Guide 2026: Formulation Comparison

GHRP-6 Acetate 20–40 min Moderate GHS-R1a affinity; minimal cortisol/prolactin cross-reactivity Strong ghrelin mimicry increases hunger 60–90 min post-dose Research protocols prioritising clean GH release with controlled feeding windows GHRP-2 15–30 min High G

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • GHRP-6 Acetate
  • 20–40 min
  • Moderate GHS-R1a affinity; minimal cortisol/prolactin cross-reactivity
  • Strong ghrelin mimicry increases hunger 60–90 min post-dose
  • Research protocols prioritising clean GH release with controlled feeding windows
  • GHRP-2
  • 15–30 min
  • High GHS-R1a affinity; moderate cortisol elevation at doses >200mcg
  • Moderate appetite increase
  • Studies requiring faster GH peak with acceptable cortisol trade-off
  • Ipamorelin
  • 30–45 min
  • High GHS-R1a selectivity; negligible cortisol/prolactin effect
  • Minimal appetite stimulation
  • Long-term protocols where cortisol elevation or appetite disruption is undesirable
  • Hexarelin
  • 10–20 min
  • Highest GHS-R1a affinity; significant desensitisation risk with chronic use
  • Strong appetite increase
  • Short-duration trials (<4 weeks) requiring maximal GH amplitude